Linked Life Data

15577118

Source:http://linkedlifedata.com/resource/pubmed/id/15577118

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-12-3
pubmed:abstractText
Marked parathyroid hyperplasia is one of the characteristic features of severe hyperparathyroidism in patients requiring chronic hemodialysis. Most of these patients become resistant to conservative therapies such as calcitriol pulse therapy. For these patients, surgical removal of the enlarged parathyroid glands is usually necessary to control parathyroid hormone secretion. Recently, hyperparathyroidism in some of these patients have been managed by percutaneous ethanol injection therapy (PEIT) due to progress of imaging technology. In this study, we consider parathyroidectomy (PTx) and PEIT as a strategy of severe hyperparathyroidism patients. We conclude that PEIT, which is safe and effective therapy for 2HPT, makes possible to maintain long-term parathyroid function within the normal range. However 20% patients after PEIT need to convert PTx:parathyroidectomy after PEIT.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0917-5857
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
88-92
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
[PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
pubmed:affiliation
Tokai University, School of Medicine.
pubmed:publicationType
Journal Article, English Abstract, Review